5-lipoxygenase-activating protein (FLAP) inhibitors

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

11538762

ABSTRACT:
Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.

REFERENCES:
patent: 5081138 (1992-01-01), Gillard et al.
patent: 2004/0198800 (2004-10-01), Allan et al.
patent: 1749829 (2006-03-01), None
Miller et al., “Identification and isolation of a membrane protein necessary for leukotrine production,” Nature 343:278-281 (1990) Abstract only.
PCT/US06/39421 Search Report dated Jan. 18, 2008.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

5-lipoxygenase-activating protein (FLAP) inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5-lipoxygenase-activating protein (FLAP) inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-lipoxygenase-activating protein (FLAP) inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3911474

All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.